M&A Deal Summary |
|
|---|---|
| Date | 2022-02-22 |
| Target | Alchemee |
| Sector | Consumer Products |
| Buyer(s) | Taro Pharmaceutical Industries |
| Sellers(s) | Galderma |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1950 |
| Sector | Life Science |
| Employees | 1,455 |
| Revenue | 561M USD (2022) |
Taro Pharmaceutical Industries is a manufacturer and developer of generic drugs and pharmaceutical components. Taro Pharmaceutical Industries was founded in 1950 and is based in Haifa, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-12-23 |
Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS
Trevose, Pennsylvania, United States Taro Pharmaceutical Industries Ltd. - U.S. Rights to KEVEYIS (dichlorphenamide) is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. |
Sell | $9M |
| Category | Company |
|---|---|
| Founded | 1981 |
| Sector | Healthcare Services |
| Employees | 6,545 |
| Revenue | 2.8B CHF (2018) |
Galderma is a global skincare company offering medical and consumer skin health solutions through three business units; aesthetics and prescription and consumer health. Galderma was founded in 1981 and is based in Zug, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Consumer Products M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-05-05 |
Galderma SA - Bubchen
Soest, Germany Galderma SA - Bubchen is a recognized skincare brand in Germany, with trusted products designed for babies and kids. |
Sell | - |
